Proinflammatory fecal mRNA and childhood bacterial enteric infections
William E. Bennett(Indiana Clinical and Translational Sciences Institute), Philip Tarr, Nurmohammad Shaikh(Washington University in St. Louis), Bao Nguyen Puente(Washington University in St. Louis), Harold J. Stevens(Pediatrics and Genetics), Donna M. Denno(University of Washington), Rosbel González-Rivera(Washington University in St. Louis), Jody Mooney(Virginia Mason Medical Center), Eileen J. Klein, Andrew Draghi(University of Connecticut), Francisco Sylvester(University of North Carolina at Chapel Hill)
Cited by 10
Related Papers
The Treatment-Naive Microbiome in New-Onset Crohn’s Disease
|Cell Host & Microbe|2014|3.3k
Global burden of diseases, injuries, and risk factors for young people's health during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013
|The Lancet|2016|999
High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis #
|Hepatology|2009|721
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
|The Lancet|2017|647
Patterned progression of bacterial populations in the premature infant gut
|Proceedings of the National Academy of Sciences|2014|586